Incyte News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.02.16	Incyte To Discontinue JANUS Studies Of Ruxolitinib Plus Capecitabine (RTTNews)
19.01.16	Lilly Submits NDA To FDA For Oral Once-Daily Baricitinib; Backs FY16 EPS View (RTTNews)
03.11.15	Incyte Announces Presentation Of Findings From Phase 1/2 Study On Epacadostat (RTTNews)
03.11.15	EARNINGS SUMMARY: Details of Incyte Corporation Q3 Earnings Report (RTTNews)
15.10.15	Shareholder Ups Stake In AFMD, Sweet Tidings From DXCM, PFE Snubbed, LLY Beams (RTTNews)
13.10.15	Incyte, Merck To Initiate Phase 3 Study For Epacadostat, Keytruda Combination (RTTNews)
30.09.15	MÄRKTE USA/Börsen folgen guten Vorgaben - Dow gewinnt 1,5% (Dow Jones)
30.09.15	MÄRKTE USA/Börsen folgen guten Vorgaben - Dow gewinnt 1% (Dow Jones)
02.09.15	Incyte In Global License Deal For SHR-1210; To Make Upfront Payment Of $25 Mln (RTTNews)
04.08.15	Incyte Turns To Profit In Q2 - Quick Facts (RTTNews)
04.08.15	EARNINGS SUMMARY: Details of Incyte Corporation Q2 Earnings Report (RTTNews)
07.07.15	Incyte,Vanderbilt University Medical Center Establish Oncology Research Alliance (RTTNews)
19.06.15	Incyte Forms Two New Units; Announces Management Changes - Quick Facts (RTTNews)
01.06.15	Advaxis Announces FDA Clearance Of IND Application For Phase 2 Study Of ADXS-HPV (RTTNews)
30.04.15	Incyte Q1 Loss Narrows - Quick Facts (RTTNews)
24.02.15	BMY, VRX Open Wallet, LLY Does It Again, RIGL Gets A Regal Touch, TRIB Is Back (RTTNews)
12.02.15	Incyte Q4 Loss Narrows - Quick Facts (RTTNews)
09.01.15	Incyte, Agenus Report Alliance To Develop Novel Immuno-Oncology Antibodies (RTTNews)
09.12.14	Eli Lilly, Incyte Say Arthritis Drug Baricitinib Meets Primary Endpoint (RTTNews)
05.12.14	CLRB Spikes Over 13%, OVAS In Good Health, INCY, MYL Get FDA Nod (RTTNews)
04.12.14	Incyte: FDA Oks Jakafi To Treat Uncontrolled Polycythemia Vera (RTTNews)
30.10.14	Incyte Turns To Profit In Q3, Results Beat Estimates; Raises FY Revenue Guidance (RTTNews)
17.10.14	Incyte Appoints David Gryska As CFO - Quick Facts (RTTNews)
02.10.14	Incyte Earns $60 Mln Milestone On Reimbursement Of Jakavi In Europe (RTTNews)
06.08.14	GMED Outlook Spooks Investors, CYTX Trials Placed On Hold, INCY Gets FDA Date (RTTNews)
31.07.14	Incyte Q2 Loss Widens, Boosts 2014 Outlook - Quick Facts (RTTNews)
08.07.14	Incyte Earns $25 Mln Milestone Payment From Novartis On Jakavi Approval In Japan (RTTNews)
03.06.14	AQXP Goes Sprinting, ARGS On Watch, BIOC Adds New Product, An Insight On RECAP (RTTNews)
27.05.14	Bristol-Myers, Incyte Establish Clinical Trial Collaboration On Immunotherapies (RTTNews)
14.05.14	AstraZeneca Says MedImmune Signs Clinical Study Collaboration With Incyte (RTTNews)
01.05.14	Incyte Q1 Loss Widens, Misses Street View - Quick Facts (RTTNews)
07.03.14	Incyte Announces Positive Top-Line Results From Phase III Study Of Ruxolitinib (RTTNews)
12.02.14	Incyte Posts Q4 Loss (RTTNews)
05.02.14	Merck Q4 Profit Down 14%, But Matches View; Sees 2014 Earnings In-line (RTTNews)
05.02.14	Merck, Amgen,Incyte And Pfizer To Collaborate On Anti-Cancer Combination Studies (RTTNews)
13.01.14	Incyte Appoints Novartis' Former Oncology Head Hervé Hoppenot As President, CEO (RTTNews)
31.10.13	Incyte Q3 Loss/Shr Narrows - Quick Facts (RTTNews)
29.10.13	INCY's Got More Proof, AKRX Hits New High, ILMN Opens Wallet, RGLS On Watch (RTTNews)
16.10.13	Dividend Announcements, Earnings Release Scheduled, and Data Presentations from Clinical Studies - Research Report on Questcor, Regeneron, NPS, Incyte, and Nektar (PR Newswire)
08.10.13	Early Briefing and Review: Arena Pharma Inc., Spectrum Pharma Inc., Incyte Corp. Ltd., and Geron Corp. (PR Newswire)
04.10.13	AMRN Faces FDA Panel On Oct.16, Isis Pockets $2Mln, NEOG Effects Stock Split (RTTNews)
03.10.13	Incyte Reports Results From INCB39110 Phase II Trial - Quick Facts (RTTNews)
27.09.13	Critical Alerts For Qihoo 360, Capital One, SunEdison, Incyte, and Tiffany Released By InvestorsObserver (PR Newswire)
29.08.13	Acquisitions, Dividends, and Positive Data - Research Report on Onyx, Johnson & Johnson, Medtronic, Lilly, and Incyte (PR Newswire)
26.08.13	Positive Clinical Trial Results, Regulatory Wins, and New Appointments - Research Report on Incyte, Edwards, ACADIA Pharmaceuticals, Alnylam, and Ironwood (PR Newswire)
22.08.13	Critical Alerts For Wells Fargo, SunEdison, Deere, Safeway, and Incyte Released By InvestorsObserver (PR Newswire)
22.08.13	Incyte Excites, ADMP Entitled To Patent, BSX Gets Two Thumbs Up, ORMP On Watch (RTTNews)
21.08.13	Pre-market Movers For Aug 21 (LOW, TGT, SPLS, AEO, INCY, QCOR, DMND) (RTTNews)
21.08.13	Biotech Companies Announce Financial Results and Receive New Patents - Research Report on Regeneron, Medivation, Incyte, Santarus, and ACADIA (PR Newswire)
21.08.13	Incyte Reports Top-line Results Of The Phase II RECAP Trial - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

04.12.24		Gewinne in New York: S&P 500 legt mittags zu
19.11.24		Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind
19.11.24		Optimismus in New York: Anleger lassen S&P 500 am Dienstagnachmittag steigen
19.11.24		Dienstagshandel in New York: S&P 500 mittags mit grünem Vorzeichen
19.11.24		Verluste in New York: S&P 500 startet im Minus
29.10.24		Börse New York in Grün: S&P 500 beendet die Sitzung im Plus
29.10.24		Börse New York: S&P 500 fester
29.10.24		Optimismus in New York: So bewegt sich der S&P 500 am Mittag

04.12.24

Gewinne in New York: S&P 500 legt mittags zu

19.11.24

Börse New York in Grün: S&P 500 zum Ende des Dienstagshandels im Aufwind

19.11.24

Optimismus in New York: Anleger lassen S&P 500 am Dienstagnachmittag steigen

19.11.24

Dienstagshandel in New York: S&P 500 mittags mit grünem Vorzeichen

19.11.24

Verluste in New York: S&P 500 startet im Minus

29.10.24

Börse New York in Grün: S&P 500 beendet die Sitzung im Plus

29.10.24

Börse New York: S&P 500 fester

29.10.24

Optimismus in New York: So bewegt sich der S&P 500 am Mittag

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Incyte Corp.

Aktien Top/Flop

Incyte Peer Group Nachrichten

Meistgelesene Nachrichten